Cargando…

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

BACKGROUND: We conducted a randomized controlled trial to investigate whether an additional platelet inhibition with tirofiban would reduce the extent of myocardial damage and prevent periprocedural myonecrosis in patients with Non-ST-elevation acute coronary syndrome (NSTE-ACS) with a high residual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wonjae, Suh, Jung-Won, Park, Jin Joo, Yoon, Chang-Hwan, Cho, Young-Seok, Youn, Tae-Jin, Chae, In-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198526/ https://www.ncbi.nlm.nih.gov/pubmed/30348101 http://dx.doi.org/10.1186/s12872-018-0938-6

Ejemplares similares

Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020)

Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hu, Sigan, et al.
Publicado: (2018)

Tirofiban: A Rare Cause of Thrombocytopenia in a Patient Undergoing Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

The Effect of Admission at Weekends on Clinical Outcomes in Patients with Non-ST-segment Elevation Acute Coronary Syndrome and Its Contributing Factors
por: Kim, Hyun-Jin, et al.
Publicado: (2015)

Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion
por: Kang, Jeehoon, et al.
Publicado: (2016)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Tian, Rui, et al.
Publicado: (2023)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Coronary Stents in Patients with ST-Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention
por: Ahmed, Khurshid, et al.
Publicado: (2012)

Genotype- and Phenotype-Directed Personalization of Antiplatelet Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Coronary Stenting
por: Ahn, Sung Gyun, et al.
Publicado: (2013)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
por: Wang, Ze-Mu, et al.
Publicado: (2023)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
por: Yi, Yi-Hu, et al.
Publicado: (2018)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
por: Yun, Kyeong Ho, et al.
Publicado: (2009)

Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Wang, Litao, et al.
Publicado: (2021)

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
por: Ji, Zhen-Guo, et al.
Publicado: (2015)

Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Li, Yan, et al.
Publicado: (2020)

Predictive value of the age, creatinine and ejection fraction score in patients undergoing primary percutaneous coronary intervention with bail-out tirofiban therapy
por: Ösken, Altuğ, et al.
Publicado: (2021)

Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Kim, Joon Young, et al.
Publicado: (2011)

Early percutaneous coronary intervention and in-hospital mortality in non st elevation coronary syndromes
por: Cebrián Domenech, J, et al.
Publicado: (2015)

Smoker's Paradox in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Tanush, et al.
Publicado: (2016)

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)
por: Jiao, Yan, et al.
Publicado: (2022)

Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice
por: Chung, Woo-Young, et al.
Publicado: (2016)

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
por: Liu, Chi, et al.
Publicado: (2022)

Effect of Sex on Neutrophil to Lymphocyte Ratio and Coronary Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Elkammash, Amr, et al.
Publicado: (2022)

Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Oh, Pyung Chun, et al.
Publicado: (2017)

Cardioprotective Effects of Intracoronary Morphine in ST‐Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial
por: Gwag, Hye Bin, et al.
Publicado: (2017)

Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial
por: Kang, Si-Hyuck, et al.
Publicado: (2017)

Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Oh, Pyung Chun, et al.
Publicado: (2020)

Effect of Operator Volume on In-Hospital Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Based on the 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Lee, Jung-Hee, et al.
Publicado: (2019)

The Operator Volume of Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Does Not Guarantee Its Quality in Korea
por: Yoon, Chang-Hwan
Publicado: (2019)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020)

Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015)

Sex Differences in Prehospital Delays in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Stehli, Julia, et al.
Publicado: (2021)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention
por: Wang, Zhisong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h7vb3b8kf691c64p9b8purloun